RNVA - Rennova Health, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Rennova Health, Inc.

400 South Australian Avenue
Suite 800
West Palm Beach, FL 33401
United States
561-855-1626
http://www.rennovahealth.com

SectorHealthcare
IndustryDiagnostics & Research
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Seamus LaganPres, CEO, Interim CFO & Director257.5kN/A1969
Ms. Karen TaylorDirector of HRN/AN/AN/A
Mr. Albert F. LechnerExec. VP of Sales - Rennova Health Technology SolutionsN/AN/AN/A
Mr. Michael AlexanderCEO of Jamestown Medical Center, Inc.N/AN/AN/A
Mr. Sebastien SainsburyCompany Sec. & PRN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Rennova Health, Inc., together with its subsidiaries, provides a suite of healthcare related products and services to healthcare providers in the United States. The company operates in two segments, Hospital Operations and Clinical Laboratory Services. It offers diagnostic imaging, radiology, surgery, nuclear medicine, wound care and hyperbaric medicine, intensive care, emergency care, and physical therapy services; and X-ray, mammography, bone densitometry, computed tomography, ultrasound, physical therapy, and laboratory services. The company also provides blood and urine, toxicology, clinical pharmacogenetics, and esoteric testing services. Rennova Health, Inc. was founded in 2005 and is based in West Palm Beach, Florida.

Corporate Governance

Rennova Health, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.